Auxilium Biotechnologies Inc.
San Diego, CA
- UEI
- JDR1KPU6KZX8
- CAGE
- 8C3Y6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4923 Bradshaw Ct, San Diego, CA 92130, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Auxilium phase 2 | Johnson Space Center | $2,068,750 | |
| Sbir i auxilium microfabrication platform cartridge modification | Shared Services Center | $146,794 | |
| The neurospan bridge: a device for peripheral nerve repair - peripheral nerve injury (PNI) occurs in 3% of all trauma… | National Institute of Neurological Disorders and Stroke | $5,094,464 | |
| Biomanufacturing in space of drug-delivery medical devices | Johnson Space Center | $4,673,184 |
About Auxilium Biotechnologies Inc.
Auxilium Biotechnologies Inc. is a for-profit corporate entity based in San Diego, California, specializing in advanced biomedical technologies and medical device development. The company focuses on innovative biotechnology solutions, with a particular emphasis on neural interface technologies, drug delivery systems, and biomedical engineering. Registered in SAM.gov since July 2019, Auxilium operates as a manufacturer of goods with expertise in developing cutting-edge medical technologies that leverage advanced scientific techniques such as microgravity research and 3D bioprinting.
Through federal contract awards, Auxilium has secured significant contracts with NASA's Johnson Space Center, demonstrating expertise in biomanufacturing technologies. The company was awarded a $2,877,734 contract to develop drug-delivery medical devices using microgravity conditions aboard the International Space Station, highlighting its innovative approach to medical device research. Additionally, Auxilium received a $146,794 Small Business Innovation Research (SBIR) Phase I contract for a microfabrication platform cartridge modification project. These contracts are not set aside for specific business types, indicating the company's competitive capabilities in advanced scientific research and development.
Auxilium's federal grant work primarily focuses on advanced neural and medical technologies. The company received a significant cooperative agreement from the National Institute of Neurological Disorders and Stroke for developing the NeuroSpan Bridge, a biomimetic multi-channel scaffold designed to repair peripheral nerve injuries. This project aims to create an innovative medical device to address nerve damage, particularly in trauma and combat scenarios. Additionally, Auxilium participated as a principal investigator in a sub-grant with the University of California, Davis, working on a brain-controlled functional electric stimulation project for spinal cord injury rehabilitation. These grants demonstrate the company's commitment to developing advanced neurological and medical technologies that address critical healthcare challenges.
SBA capabilities narrative
Bioengineering of therapeutic implants using 3D printing
Quick answers
What is Auxilium Biotechnologies Inc.'s UEI?
Auxilium Biotechnologies Inc.'s Unique Entity ID (UEI) in SAM.gov is JDR1KPU6KZX8.
What is Auxilium Biotechnologies Inc.'s CAGE code?
Auxilium Biotechnologies Inc.'s CAGE code is 8C3Y6.
What is Auxilium Biotechnologies Inc.'s primary NAICS code?
Auxilium Biotechnologies Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Auxilium Biotechnologies Inc. located?
Auxilium Biotechnologies Inc.'s physical address in SAM.gov is 4923 Bradshaw Ct, San Diego, CA 92130, USA.
Is Auxilium Biotechnologies Inc. registered in SAM.gov?
Yes. Auxilium Biotechnologies Inc.'s SAM.gov registration is active through April 14, 2027.
What is Auxilium Biotechnologies Inc.'s most recent federal award?
Auxilium Biotechnologies Inc.'s most recent federal contract award is Auxilium phase 2 (80JSC026C0006), from Johnson Space Center, on July 1, 2026.
On GovTribe
See Auxilium Biotechnologies Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors